Original news and analysis on international IP policy
Según un nuevo documento elaborado para el Grupo de Trabajo sobre el Derecho al Desarrollo de Naciones Unidas, la estrategia mundial sobre salud y propiedad intelectual de la Organización Mundial de la Salud (OMS) comprende elementos sólidos y posibles cambios paradigmáticos; sin embargo, también presenta lagunas considerables en cuanto a derechos humanos.
一份即将呈交给联合国发展权工作小组的文件说，世界卫生组织在保护健康和知识产权方面的全球战略虽然囊括了强有力并有可能创新模式的因素，但在人权方面仍有显著缺憾。
تحتوي الاستراتيجية العالمية بشأن الصحة والملكية الفكرية لمنظمة الصحة العالمية على عناصر قوية من شأنها أن تغير النماذج ولكنها تتضمن أيضا أوجه قصور بارزة في ما يتعلق بحقوق الإنسان، كما تفيد بذلك وثيقة جديدة أُعدت لفريق الأمم المتحدة المسؤول عن…
Les éléments qui composent la stratégie mondiale pour la santé publique et la propriété intellectuelle de l’Organisation mondiale de la Santé sont d’une grande portée et pourraient même entraîner un bouleversement de l’ordre établi. Toutefois, selon un rapport élaboré à l’attention du Groupe de travail sur le droit au développement des Nations Unies, cette stratégie présente des limites notables en matière de droits de l’homme.
The latest news on people in the international IP community.
The World Health Organization global strategy on health and intellectual property includes powerful and potentially paradigm-shifting elements, but it also has notable shortcomings for human rights, says a new document prepared for the United Nations group responsible for the right to development.
NAIROBI - Governments in Kenya and other developing nations must be willing to provide financial incentives if they expect companies to carry out research and development of drugs specifically tailored to those countries' needs, a conference in Nairobi was told last week.
The World Health Organization on Friday issued a statement on a high-profile debate over Dutch customs authorities’ delays of shipments of legitimate generic pharmaceuticals passing through the European country on their way to patients in developing countries. The goods were apparently believed to be counterfeit medicines.
Health advocates on Friday escalated their alarm over recent seizures by the Dutch government of shipments of legitimate generic pharmaceuticals passing through Europe on their way to developing countries. The European Commission has defended its actions as permissible under its own and international rules, but is being asked to look more carefully at those rules.
The World Health Organization is soliciting new ideas for funding sources to stimulate research and development on diseases predominantly afflicting developing countries, with some in developed countries. The web-based public hearing, being held online from 7 March to 15 April, will contribute to an intergovernmental mandate to come up with ways to address the shortage of research in this areas.